Early research (Phase 1)Study completedNCT01284582
What this trial is testing
Safety, Immunogenicity and Dose Response of ATH03, a New Vaccine Against the Cholesterol Ester Transfer Protein (CETP)
Who this might be right for
HDLDrug Safety
Affiris AG 36